Cargando…

Region-Specific Neuroprotective Features of Astrocytes against Oxidative Stress Induced by 6-Hydroxydopamine

In previous studies, we found regional differences in the induction of antioxidative molecules in astrocytes against oxidative stress, postulating that region-specific features of astrocytes lead region-specific vulnerability of neurons. We examined region-specific astrocytic features against dopami...

Descripción completa

Detalles Bibliográficos
Autores principales:	Asanuma, Masato, Okumura-Torigoe, Nao, Miyazaki, Ikuko, Murakami, Shinki, Kitamura, Yoshihisa, Sendo, Toshiaki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6387089/ https://www.ncbi.nlm.nih.gov/pubmed/30704073 http://dx.doi.org/10.3390/ijms20030598

Ejemplares similares

Mirtazapine exerts astrocyte-mediated dopaminergic neuroprotection
por: Kikuoka, Ryo, et al.
Publicado: (2020)

l-Theanine protects against excess dopamine-induced neurotoxicity in the presence of astrocytes
por: Takeshima, Mika, et al.
Publicado: (2016)

Striatal Astrocytes Act as a Reservoir for L-DOPA
por: Asanuma, Masato, et al.
Publicado: (2014)

3-O-Methyldopa inhibits astrocyte-mediated dopaminergic neuroprotective effects of l-DOPA
por: Asanuma, Masato, et al.
Publicado: (2016)

Neuron-Astrocyte Interactions in Parkinson’s Disease
por: Miyazaki, Ikuko, et al.
Publicado: (2020)

Multifunctional Metallothioneins as a Target for Neuroprotection in Parkinson’s Disease
por: Miyazaki, Ikuko, et al.
Publicado: (2023)

Serotonin 1A Receptors on Astrocytes as a Potential Target for the Treatment of Parkinson’s Disease
por: Miyazaki, Ikuko, et al.
Publicado: (2016)

Effects of Enteric Environmental Modification by Coffee Components on Neurodegeneration in Rotenone-Treated Mice
por: Miyazaki, Ikuko, et al.
Publicado: (2019)

Lack of Dopaminergic Inputs Elongates the Primary Cilia of Striatal Neurons
por: Miyoshi, Ko, et al.
Publicado: (2014)

Glutathione and Related Molecules in Parkinsonism
por: Asanuma, Masato, et al.
Publicado: (2021)

Design, Synthesis, and Neuroprotective Effects of a Series of Pyrazolines against 6-Hydroxydopamine-Induced Oxidative Stress
por: Özdemir, Ahmet, et al.
Publicado: (2018)

Effectiveness of medical supportive team for outpatients treated with sorafenib: a retrospective study
por: Kajizono, Makoto, et al.
Publicado: (2015)

Neuroprotective Effects of Erucin against 6-Hydroxydopamine-Induced Oxidative Damage in a Dopaminergic-like Neuroblastoma Cell Line
por: Tarozzi, Andrea, et al.
Publicado: (2012)

Association of astrocytes with neurons and astrocytes derived from distinct progenitor domains in the subpallium
por: Torigoe, Makio, et al.
Publicado: (2015)

Clinical risk factors associated with postoperative delirium and evaluation of delirium management and assessment team in lung and esophageal cancer patients
por: Murakawa, Kiminaka, et al.
Publicado: (2015)

Neuroprotective Effect of Pseudoginsenoside-F11 on a Rat Model of Parkinson's Disease Induced by 6-Hydroxydopamine
por: Wang, Jian Yu, et al.
Publicado: (2013)

Berberine chloride pretreatment exhibits neuroprotective effect against 6-hydroxydopamine-induced neuronal insult in rat
por: Negahdar, Feraidoon, et al.
Publicado: (2015)

Neuroprotective Effect of Quercetin Nanocrystal in a 6-Hydroxydopamine Model of Parkinson Disease: Biochemical and Behavioral Evidence
por: Ghaffari, Fatemeh, et al.
Publicado: (2018)

Neuroprotective Activity of Some Marine Fungal Metabolites in the 6-Hydroxydopamin- and Paraquat-Induced Parkinson’s Disease Models
por: Yurchenko, Ekaterina A., et al.
Publicado: (2018)

Sea Anemone Kunitz-Type Peptides Demonstrate Neuroprotective Activity in the 6-Hydroxydopamine Induced Neurotoxicity Model
por: Sintsova, Oksana, et al.
Publicado: (2021)

Treatment with a Substance P Receptor Antagonist Is Neuroprotective in the Intrastriatal 6-Hydroxydopamine Model of Early Parkinson's Disease
por: Thornton, Emma, et al.
Publicado: (2012)

Neuroprotective Effect of Thymoquinone, the Nigella Sativa Bioactive Compound, in 6-Hydroxydopamine-Induced Hemi-Parkinsonian Rat Model
por: Sedaghat, Reza, et al.
Publicado: (2014)

High-Frequency Stimulation of the Rat Entopeduncular Nucleus Does Not Provide Functional or Morphological Neuroprotection from 6-Hydroxydopamine
por: Fischer, D. Luke, et al.
Publicado: (2015)

Tetramethylpyrazine Analogue T-006 Exerts Neuroprotective Effects against 6-Hydroxydopamine-Induced Parkinson's Disease In Vitro and In Vivo
por: Zhou, Hefeng, et al.
Publicado: (2019)

Oxidation of DJ-1 Induced by 6-Hydroxydopamine Decreasing Intracellular Glutathione
por: Miyama, Akiko, et al.
Publicado: (2011)

Neuroprotective Effects of Herbal Ethanol Extracts from Gynostemma pentaphyllum in the 6-Hydroxydopamine-Lesioned Rat Model of Parkinson's Disease
por: Choi, Hyun Sook, et al.
Publicado: (2010)

Neuroprotective effects of insulin-like growth factor-2 in 6-hydroxydopamine-induced cellular and mouse models of Parkinson’s disease
por: Zhang, Hai-Ying, et al.
Publicado: (2022)

Estrogen-Astrocyte interactions: Implications for neuroprotection
por: Dhandapani, Krishnan M, et al.
Publicado: (2002)

Astrocytes Do Not Forfeit Their Neuroprotective Roles After Surviving Intense Oxidative Stress
por: Bhatia, Tarun N., et al.
Publicado: (2019)

A cross-sectional study of psychological distress, burnout, and the associated risk factors in hospital pharmacists in Japan
por: Higuchi, Yuji, et al.
Publicado: (2016)

AN69ST membranes adsorb nafamostat mesylate and affect the management of anticoagulant therapy: a retrospective study
por: Hirayama, Takahiro, et al.
Publicado: (2017)

Repressing PTBP1 fails to convert reactive astrocytes to dopaminergic neurons in a 6-hydroxydopamine mouse model of Parkinson’s disease
por: Chen, Weizhao, et al.
Publicado: (2022)

Pre-α-pro-GDNF and Pre-β-pro-GDNF Isoforms Are Neuroprotective in the 6-hydroxydopamine Rat Model of Parkinson's Disease
por: Penttinen, Anna-Maija, et al.
Publicado: (2018)

Dual-Hit Model of Parkinson’s Disease: Impact of Dysbiosis on 6-Hydroxydopamine-Insulted Mice—Neuroprotective and Anti-Inflammatory Effects of Butyrate
por: Avagliano, Carmen, et al.
Publicado: (2022)

Africanized Bee Venom (Apis mellifera Linnaeus): Neuroprotective Effects in a Parkinson’s Disease Mouse Model Induced by 6-hydroxydopamine
por: Dantas, Camila G., et al.
Publicado: (2022)

High Glucose Increases Metallothionein Expression in Renal Proximal Tubular Epithelial Cells
por: Ogawa, Daisuke, et al.
Publicado: (2011)

Transplantation of Melanocytes Obtained from the Skin Ameliorates Apomorphine-Induced Abnormal Behavior in Rodent Hemi-Parkinsonian Models
por: Asanuma, Masato, et al.
Publicado: (2013)

Chronic Systemic Exposure to Low-Dose Rotenone Induced Central and Peripheral Neuropathology and Motor Deficits in Mice: Reproducible Animal Model of Parkinson’s Disease
por: Miyazaki, Ikuko, et al.
Publicado: (2020)

Fingolimod induces neuroprotective factors in human astrocytes
por: Hoffmann, Franziska S., et al.
Publicado: (2015)

Current opinion on a role of the astrocytes in neuroprotection
por: Teo, Leon, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_4l2rc97ol99kg0e2sbm6lltlb2